(EYPT) Eyepoint Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Eyepoint Pharmaceuticals | (EYPT) share price targets
Complete technical analysis of Eyepoint Pharmaceuticals (EYPT) by charts plus indicators, forecast predictions and share price targets for Eyepoint Pharmaceuticals (EYPT)
Eyepoint Pharmaceuticals trades in USA in Capital Goods sector.
Showing technical analysis as on 2024-09-04 View latest technical analysis
10 day averaged volume of Eyepoint Pharmaceuticals is 436394
| Date | Daily Closing Price | Open | High | Low | Volume |
| 04 Wed Sep 2024 | 8.36 | 8.15 | 8.56 | 8.10 | 0.618 times |
| 03 Tue Sep 2024 | 8.16 | 8.82 | 8.94 | 8.08 | 1.009 times |
| 30 Fri Aug 2024 | 8.95 | 8.75 | 9.06 | 8.58 | 0.81 times |
| 30 Fri Aug 2024 | 8.95 | 8.75 | 9.06 | 8.58 | 0.81 times |
| 29 Thu Aug 2024 | 8.72 | 8.91 | 9.09 | 8.71 | 0.796 times |
| 28 Wed Aug 2024 | 8.82 | 9.40 | 9.57 | 8.76 | 0.866 times |
| 27 Tue Aug 2024 | 9.09 | 9.20 | 9.25 | 8.87 | 0.534 times |
| 26 Mon Aug 2024 | 9.30 | 9.30 | 9.48 | 9.16 | 0.776 times |
| 23 Fri Aug 2024 | 9.19 | 9.02 | 9.59 | 9.00 | 1.525 times |
| 22 Thu Aug 2024 | 9.00 | 9.25 | 9.50 | 8.76 | 1.07 times |
My analysis of stock is bearish for shortterm, and stock might move down till 8 or till 7.4. Use a stoploss of 8.56 and if the stock hits stoploss, then it can shoot up till 9.09
Share price targets for Eyepoint Pharmaceuticals (EYPT)
| Target Type | Value |
| Downside Target | 7.40 |
| Downside Target | 7.67 |
| Downside Target | 7.95 |
| Upside Target | 8.58 |
| Upside Target | 8.79 |
| Upside Target | 9.57 |
| Upside Target | 9.59 |
| Upside Target | 10.00 |
| Upside Target | 10.41 |
| Upside Target | 10.94 |
| Upside Target | 11.24 |
| Upside Target | 21.26 |
Intraday share price targets for Eyepoint Pharmaceuticals (EYPT)
| Target Type | Value |
| Downside Intraday Target | 7.98 |
| Downside Intraday Target | 7.6 |
| Upside Intraday Target | 8.84 |
| Upside Intraday Target | 9.32 |
| Upside Intraday Target | 8.46 |
Weekly technical analysis of Eyepoint Pharmaceuticals (EYPT)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 04 Wed Sep 2024 | 8.36 | 8.82 | 8.94 | 8.08 | 2.01 times |
| 30 Fri Aug 2024 | 8.95 | 8.75 | 9.06 | 8.58 | 0.214 times |
| 30 Fri Aug 2024 | 8.95 | 9.30 | 9.57 | 8.58 | 0.594 times |
| 23 Fri Aug 2024 | 9.19 | 7.96 | 9.59 | 7.67 | 0.646 times |
| 16 Fri Aug 2024 | 7.93 | 8.73 | 8.79 | 7.40 | 1.378 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Eyepoint Pharmaceuticals (EYPT)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 04 Wed Sep 2024 | 8.36 | 8.82 | 8.94 | 8.08 | 0.053 times |
| 30 Fri Aug 2024 | 8.95 | 9.86 | 10.00 | 7.40 | 0.77 times |
| 31 Wed Jul 2024 | 9.88 | 8.68 | 11.24 | 7.73 | 0.903 times |
| 28 Fri Jun 2024 | 8.70 | 10.70 | 10.94 | 7.95 | 0.589 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Eyepoint Pharmaceuticals (EYPT)
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Eyepoint Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Eyepoint Pharmaceuticals in short term but the buy signal is initial and weak.
Eyepoint Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Eyepoint Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Eyepoint Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.87 and Eyepoint Pharmaceuticals (EYPT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eyepoint Pharmaceuticals (EYPT) stock. Volume based technical analysis of Eyepoint Pharmaceuticals (EYPT) stock is negative.
Eyepoint Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Eyepoint Pharmaceuticals ( (EYPT) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Eyepoint Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Eyepoint Pharmaceuticals in short term but the buy signal is initial and weak.
Eyepoint Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Eyepoint Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Eyepoint Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.87 and Eyepoint Pharmaceuticals (EYPT) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eyepoint Pharmaceuticals (EYPT) stock. Volume based technical analysis of Eyepoint Pharmaceuticals (EYPT) stock is negative.
Eyepoint Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.